RNA's Advantages Over Other Cell Therapies with Cartesian's CSO
- Author
- Erin Harris
- Published
- Thu 06 Jan 2022
- Episode Link
- None
We love to hear from our listeners. Send us a message.
Dr. Michael Singer, CSO at Cartesian Therapeutics, details why RNA has advantages over other cell therapies, the company's three RNA trials, and the therapeutic benefit of multiple modifications.
Subscribe to the podcast!
Apple | Spotify | YouTube
Visit my website: Cell & Gene
Connect with me on LinkedIn
